These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7893925)

  • 1. Inhibition of clot-bound and free (fluid-phase thrombin) by a novel synthetic thrombin inhibitor (Ro 46-6240), recombinant hirudin and heparin in human plasma.
    Gast A; Tschopp TB; Schmid G; Hilpert K; Ackermann J
    Blood Coagul Fibrinolysis; 1994 Dec; 5(6):879-87. PubMed ID: 7893925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of extrinsic and intrinsic thrombin generation by a novel synthetic thrombin inhibitor (Ro 46-6240), recombinant hirudin and heparin in human plasma.
    Gast A; Tschopp TB
    Blood Coagul Fibrinolysis; 1995 Sep; 6(6):553-60. PubMed ID: 7578898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
    Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
    J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the synthetic thrombin inhibitor argatroban on fibrin- or clot-incorporated thrombin: comparison with heparin and recombinant Hirudin.
    Berry CN; Girardot C; Lecoffre C; Lunven C
    Thromb Haemost; 1994 Sep; 72(3):381-6. PubMed ID: 7855788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Finkle CD; St Pierre A; Leblond L; Deschenes I; DiMaio J; Winocour PD
    Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of SanOrg123781A, a synthetic hexadecasaccharide, on clot-bound thrombin and factor Xa in vitro and in vivo.
    Hérault JP; Cappelle M; Bernat A; Millet L; Bono F; Schaeffer P; Herbert JM
    J Thromb Haemost; 2003 Sep; 1(9):1959-65. PubMed ID: 12941037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet aggregation induced in vitro by rabbit plasma clot-associated thrombin, and its inhibition by thrombin inhibitors.
    Gandossi E; Lunven C; Gauffeny C; Roome NO; Berry CN
    Thromb Haemost; 1998 Nov; 80(5):840-4. PubMed ID: 9843181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrin-targeted recombinant hirudin inhibits fibrin deposition on experimental clots more efficiently than recombinant hirudin.
    Bode C; Hudelmayer M; Mehwald P; Bauer S; Freitag M; von Hodenberg E; Newell JB; Kübler W; Haber E; Runge MS
    Circulation; 1994 Oct; 90(4):1956-63. PubMed ID: 7923685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of thrombin compared with factor Xa in the procoagulant activity of whole blood clots.
    Prager NA; Abendschein DR; McKenzie CR; Eisenberg PR
    Circulation; 1995 Aug; 92(4):962-7. PubMed ID: 7641380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the inhibition of both clot-associated thrombin and factor Xa more clinically relevant than either one alone?
    Meddahi S; Samama MM
    Blood Coagul Fibrinolysis; 2009 Apr; 20(3):207-14. PubMed ID: 19657318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained antithrombotic activity of hirudin after its plasma clearance: comparison with heparin.
    Agnelli G; Renga C; Weitz JI; Nenci GG; Hirsh J
    Blood; 1992 Aug; 80(4):960-5. PubMed ID: 1498336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of prothombinase activation after adding human purified prothrombin to human clot: comparison of hirudin, an activated factor II inhibitor, with DX9065a, an activated factor X inhibitor, on clot-associated thrombin and on prothrombin activation.
    Meddahi S; Bara L; Fessi H; Samama MM
    Blood Coagul Fibrinolysis; 2005 Mar; 16(2):125-33. PubMed ID: 15741800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the inhibition by heparin and hirudin of coagulation activation during r-tPA-induced thrombolysis.
    Mirshahi M; Soria J; Soria C; Faivre R; Lu H; Courtney M; Roitsch C; Tripier D; Caen JP
    Blood; 1989 Aug; 74(3):1025-30. PubMed ID: 2502207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors.
    Weitz JI; Leslie B; Hudoba M
    Circulation; 1998 Feb; 97(6):544-52. PubMed ID: 9494024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by Argatroban, a specific thrombin inhibitor, of platelet activation by fibrin clot-associated thrombin.
    Lunven C; Gauffeny C; Lecoffre C; O'Brien DP; Roome NO; Berry CN
    Thromb Haemost; 1996 Jan; 75(1):154-60. PubMed ID: 8713795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of concomitant thrombin-mediated fibrin formation enhances clot lysis in whole blood.
    Haskel EJ; Eisenberg PR; Abendschein DR
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):7-13. PubMed ID: 8457655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors.
    Kirchhofer D; Tschopp TB; Hadváry P; Baumgartner HR
    J Clin Invest; 1994 May; 93(5):2073-83. PubMed ID: 8182139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial.
    Rao AK; Sun L; Chesebro JH; Fuster V; Harrington RA; Schwartz D; Gallo P; Matos D; Topol EJ
    Circulation; 1996 Nov; 94(10):2389-95. PubMed ID: 8921778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of heparin, hirudin, and a synthetic thrombin inhibitor on antithrombin III in thrombin-induced disseminated intravascular coagulation in rats.
    Hauptmann J; Brüggener E; Markwardt F
    Haemostasis; 1987; 17(6):321-8. PubMed ID: 3428717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoassay for the detection of active-site specific thrombin inhibitors in biological fluids. II. Heparin affects the binding of hirudin to alpha-thrombin.
    Lackmann M; Geczy CL
    Thromb Res; 1991 Sep; 63(6):609-16. PubMed ID: 1780805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.